Opera adds built-in Instagram to its desktop browser
OSLO, Norway, April 22, 2020 (GLOBE NEWSWIRE) — Opera [NASDAQ: OPRA] is adding a built-in Instagram feature to the newest […]
Nasdaq Reports First Quarter 2020 Results, Adapts to COVID-19 While Delivering for Clients
Nasdaq thanks all front-line workers who are committed to providing essential services to those impacted by the COVID-19 pandemic. The […]
Nasdaq Announces 4% Increase in Quarterly Dividend to $0.49 Per Share
NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a […]
CDW to Announce First Quarter 2020 Results on May 6
LINCOLNSHIRE, Ill., April 22, 2020 (GLOBE NEWSWIRE) — CDW Corporation (Nasdaq:CDW), a leading multi-brand technology solutions provider to business, government, […]
Universal Stainless Reports First Quarter 2020 Results
Q1 2020 Sales total $58.5 million; Aerospace sales rise 12.7% sequentiallyQ1 2020 Net Loss of $1.4 million, or $0.16 per […]
FirstCash Reports First Quarter Revenues and Earnings; Adds 67 Locations with Acquisition & New Store Openings; Provides COVID-19 Update
FORT WORTH, Texas, April 22, 2020 (GLOBE NEWSWIRE) — FirstCash, Inc. (the “Company”) (Nasdaq: FCFS), the leading international operator of […]
SPI Energy to Hold Investor Webinar and Q&A Session with the Management on April 22
HONG KONG and SANTA CLARA, Calif., April 22, 2020 (GLOBE NEWSWIRE) — SPI Energy Co., Ltd. (“SPI Energy” or the […]
SPI Energy Announces Acquisition of the Cork Solar Project
HONG KONG and SANTA CLARA, Calif., April 22, 2020 (GLOBE NEWSWIRE) — SPI Energy Co., Ltd. (“SPI Energy” or the […]
Chi-Med Highlights Presentations of Surufatinib at the Upcoming AACR Virtual Annual Meetings
LONDON, April 22, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announces that new and updated […]
Celyad to Host Remote 2020 Ordinary General Meeting
MONT-SAINT-GUIBERT, Belgium, April 22, 2020 (GLOBE NEWSWIRE) — Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company […]
